Date Filed | Type | Description |
10/12/2023 |
8-K
| Quarterly results |
10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
10/04/2023 |
4
| BERMAN MICHAEL (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 3,106 shares
@ $0 |
|
10/04/2023 |
4
| Arnold Kathryn (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 1,364 shares
@ $0 |
|
10/04/2023 |
4
| ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 2,652 shares
@ $0 |
|
10/04/2023 |
4
| Kester Thomas J (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 2,614 shares
@ $0 |
|
08/08/2023 |
8-K
| Quarterly results |
08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
07/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
07/21/2023 |
8-K
| Quarterly results |
07/18/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
07/05/2023 |
4
| ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 3,445 shares
@ $0 |
|
07/05/2023 |
4
| Kester Thomas J (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 3,396 shares
@ $0 |
|
07/05/2023 |
4
| BERMAN MICHAEL (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 4,351 shares
@ $0 |
|
07/05/2023 |
4
| Arnold Kathryn (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 1,772 shares
@ $0 |
|
06/16/2023 |
SC 13D
| Shore Craig reports a 8% stake in InspireMD, Inc. |
06/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
05/24/2023 |
SC 13G
| Soleus Private Equity Fund III, L.P. reports a 9.9% stake in InspireMD, Inc. |
05/23/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
05/23/2023 |
8-K
| Investor presentation |
05/19/2023 |
4
| Slosman Marvin (CEO and President) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 1,045,150 restricted stock units
@ $0 Granted 348,380 options to buy
@ $1.76, valued at
$613.1k
|
|
05/19/2023 |
4
| Shore Craig (CFO and CAO) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 522,580 shares
@ $0 Granted 174,190 options to buy
@ $1.76, valued at
$306.6k
|
|
05/19/2023 |
4
| Stuka Paul (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 225,680 shares
@ $0 Granted 75,220 options to buy
@ $1.76, valued at
$132.4k
|
|
05/19/2023 |
4
| Gleason Shane Thomas (VP Global Marketing) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 256,450 shares
@ $0 Granted 85,480 options to buy
@ $1.76, valued at
$150.4k
|
|
05/19/2023 |
4
| BERMAN MICHAEL (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 149,260 shares
@ $0 Granted 49,750 options to buy
@ $1.76, valued at
$87.6k
|
|
05/19/2023 |
4
| Tommasoli Andrea (COO) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 179,080 shares
@ $0 Granted 59,690 options to buy
@ $1.76, valued at
$105.1k
|
|
05/19/2023 |
4
| Kester Thomas J (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 149,260 shares
@ $0 Granted 49,750 options to buy
@ $1.76, valued at
$87.6k
|
|
05/19/2023 |
4
| ROUBIN GARY S (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 149,260 shares
@ $0 Granted 49,750 options to buy
@ $1.76, valued at
$87.6k
|
|
05/19/2023 |
4
| Arnold Kathryn (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Granted 149,260 shares
@ $0 Granted 49,750 options to buy
@ $1.76, valued at
$87.6k
|
|
05/16/2023 |
4
| Stuka Paul (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Bought 175,000 shares
@ $1.6327, valued at
$285.7k
Bought 87,500 options to buy
@ $1.3827, valued at
$121k
|
|
05/16/2023 |
4
| Kester Thomas J (Director) has filed a Form 4 on InspireMD, Inc.
Txns:
| Bought 61,249 shares
@ $1.6327, valued at
$100k
Bought 30,625 options to buy
@ $1.3827, valued at
$42.3k
Bought 30,624 options to buy
@ $1.3827, valued at
$42.3k
|
|
|